Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karl B. Hansen is active.

Publication


Featured researches published by Karl B. Hansen.


Angewandte Chemie | 1999

Regio- and Enantioselective Cyclization of Epoxy Alcohols Catalyzed by a [CoIII(salen)] Complex

Michael H. Wu; Karl B. Hansen; Eric N. Jacobsen

The intramolecular cyclization of epoxy alcohols was catalyzed with excellent regio- and enantiocontrol by a [CoIII(salen)] complex. High endo selectivity was observed for the enantioselective cyclization of terminal epoxy alcohols [Eq. (a)], while the reaction of meso substrates produced novel cyclic and bicyclic ethers in good yields and high enantiopurity. TBME=tert-butyl methyl ether.


Journal of the American Chemical Society | 2008

A Case of Remote Asymmetric Induction in the Peptide-Catalyzed Desymmetrization of a Bis(phenol)

Chad A. Lewis; Jeffrey L. Gustafson; Anna Chiu; Jaume Balsells; David Pollard; Jerry Murry; Robert A. Reamer; Karl B. Hansen; Scott J. Miller

We report a catalytic approach to the synthesis of a key intermediate on the synthetic route to a pharmaceutical drug candidate in single enantiomer form. In particular, we illustrate the discovery process employed to arrive at a powerful, peptide-based asymmetric acylation catalyst. The substrate this catalyst modifies represents a remarkable case of desymmetrization, wherein the enantiotopic groups are separated by nearly a full nanometer, and the distance between the reactive site and the pro-stereogenic element is nearly 6 A. Differentiation of enantiotopic sites within molecules that are removed from the prochiral centers by long distances presents special challenges to the field of asymmetric catalysis. As the distance between enantiotopic sites increases within a substrate, so too may the requirements for size and complexity of the catalyst. The approach presented herein contrasts enzymatic catalysts and small-molecule catalysts for this challenge. Ultimately, we report here a synthetic, miniaturized enzyme mimic that catalyzes a desymmetrization reaction over a substantial distance. In addition, studies relevant to mechanism are presented, including (a) the delineation of structure-selectivity relationships through the use of substrate analogs, (b) NMR experiments documenting catalyst-substrate interactions, and (c) the use of isotopically labeled substrates to illustrate unequivocally an asymmetric catalyst-substrate binding event.


Angewandte Chemie | 1999

DURCH EINEN (SALEN)COIII-KOMPLEX KATALYSIERTE REGIO- UND ENANTIOSELEKTIVE CYCLISIERUNG VON EPOXYALKOHOLEN

Michael H. Wu; Karl B. Hansen; Eric N. Jacobsen

Mit exzellenter Regio-und Enantiokontrolle katalysieren [(salen)CoIII]-Komplexe die intramolekulare Cyclisierung von Epoxyalkoholen. Terminale Epoxyalkohole werden mit hoher endo-Selektivitat enantioselektiv cyclisiert [Gl. (a)]. Die Reaktion von meso-Substraten fuhrte in guten Ausbeuten zu neuartigen cyclischen und bicyclischen Ethern mit hoher Enantiomerenreinheit. TBME=tert-Butylmethylether.


Journal of Organic Chemistry | 2011

Practical Syntheses of a CXCR3 Antagonist

Johann Chan; Brenda J. Burke; Kyle D. Baucom; Karl B. Hansen; Matthew M. Bio; Evan DiVirgilio; Margaret M. Faul; Jerry Murry

Two new, reliable syntheses of a pyrido[2,3-d]-pyrimidine inhibitor of the CXCR3 receptor are described. A nine-step synthesis of the CXCR3 inhibitor (1) from 2-aminonicotinic acid was demonstrated on a multikilogram scale and incorporates a classic resolution to deliver the enantioenriched active pharmaceutical ingredient (API). A second synthesis of the CXCR3 inhibitor starts from (+)-(D)-Boc alanine and 2-chloronicotinic acid and utilizes a Goldberg coupling. This second synthesis, performed on a gram scale, intersects the former route at a common intermediate thereby completing a formal synthesis of the enantioenriched API in higher overall yield without the need for a resolution.


Journal of the American Chemical Society | 2002

Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides Catalyzed by Chiral (salen)CoIII Complexes. Practical Synthesis of Enantioenriched Terminal Epoxides and 1,2-Diols

Scott E. Schaus; Bridget D. Brandes; Jay F. Larrow; Makoto Tokunaga; Karl B. Hansen; Alexandra E. Gould; Michael E. Furrow; Eric N. Jacobsen


Journal of the American Chemical Society | 1996

On the Mechanism of Asymmetric Nucleophilic Ring-Opening of Epoxides Catalyzed by (Salen)CrIII Complexes

Karl B. Hansen; and James L. Leighton; Eric N. Jacobsen


Angewandte Chemie | 1995

CARBENOID TRANSFER TO IMINES : A NEW ASYMMETRIC CATALYTIC SYNTHESIS OF AZIRIDINES

Karl B. Hansen; Nathaniel S. Finney; Eric N. Jacobsen


Archive | 2004

Phosphoric acid salt of a dipeptidyl peptidase IV inhibitor.

Stephen Howard Cypes; Alex M. Chen; Russell R. Ferlita; Karl B. Hansen; Ivan Lee; Vicky K. Vydra; Robert M. Wenslow


Angewandte Chemie | 1997

On the Viability of Oxametallacyclic Intermediates in the (salen)Mn‐Catalyzed Asymmetric Epoxidation

Nathaniel S. Finney; Paul J. Pospisil; Sukbok Chang; Michael Palucki; Reed G. Konsler; Karl B. Hansen; Eric N. Jacobsen


Organic Process Research & Development | 2005

First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin

Karl B. Hansen; Jaume Balsells; Spencer D. Dreher; Yi Hsiao; Michele Kubryk; Michael Palucki; Nelo R. Rivera; Dietrich Steinhuebel; Joseph D. Armstrong; David Askin; Edward J. J. Grabowski

Collaboration


Dive into the Karl B. Hansen's collaboration.

Researchain Logo
Decentralizing Knowledge